Salbutamol Recruiting Phase 1 Trials for Lymphangioleiomyomatosis Treatment

IndicationsStatusPurposePhase
RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01799538Nebulized or Inhaled Albuterol for Lymphangioleiomyomatosis